NCT00108537View on ClinicalTrials.gov

Non-Nicotine Agents for Smoking Cessation

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2003

Study Completion Date

September 30, 2005

Conditions
Tobacco Use Disorder
Interventions
DRUG

bupropion and transdermal patch

DRUG

transdermal patch and nicotine inhaler

Trial Locations (1)

80220

Denver VA Medical Center, Denver

All Listed Sponsors
lead

US Department of Veterans Affairs

FED

NCT00108537 - Non-Nicotine Agents for Smoking Cessation | Biotech Hunter | Biotech Hunter